BLTE Exercise Disclosure
Chen Wan-shan · SEC Form 4 · Filed Oct 30, 2026
Exercise
Calculated transaction value
$0
Chen Wan-shan Director
BLTE
Belite Bio, Inc
BLTE
Transaction date
Sep 24, 2026
Public filing date
Oct 30, 2026
Filing lag
Filed 36 days later
BLTE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Ordinary Shares
- Quantity / price
- 13,796 shares @ $0
- SEC ownership
- Direct
- Transaction code
- X
- Form
- 4
- Filing identifier
- 0001193125-26-442228
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$6.05K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Belite Bio, Inc BLTE | Exercise | Sep 24, 2026 | $6.05K |
| Belite Bio, Inc BLTE Current | Exercise | Sep 24, 2026 | $0 |